Kazuhiro Gomi

Prof. Kazuhiro Gomi

Director, Tsurumi University, School of Dental medicine Hospital
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Journal of Periodontology
Verified
Journal Article
Closed access
Kazuhiro GomiKazuhiro Gomi
Kazuhiro Gomi
AYAkihiro Yashima
Akihiro Yashima
TNTakatoshi Nagano
Takatoshi Nagano
MKMikimoto Kanazashi
Mikimoto Kanazashi
NMNobuko Maeda
Nobuko Maeda
TATakashi Arai
Takashi Arai
Background: One‐stage full‐mouth disinfection (FMD), in which full‐mouth scaling and root planing (SRP) is performed with adjunctive use of chlorhexidine, was introduced in 1995. There have been several reports on the effectiveness of this treatment protocol. However, FMD was reported to induce pyrexia frequently. We examined the effects of full‐mouth SRP in conjunction with azithromycin administered orally before SRP to control the number of bacteria. The purpose of this study was to compare the effects of full‐mouth SRP using azithromycin with conventional SRP.Methods: Thirty‐four subjects (17 in the test group and 17 in the control group) with severe chronic periodontitis were selected. The subjects of the test group had azithromycin 3 days before full‐mouth SRP. Clinical parameters (probing depth [PD], gingival index [GI], bleeding on probing [BOP], and gingival crevicular fluid [GCF]), total number of bacteria, and number of black pigment‐producing rods (BPRs) were evaluated at baseline and 5, 13, and 25 weeks after baseline.Results: All clinical parameters improved in the test group more than in the control group. In the bacteriologic examination, the total number of bacteria did not change during the examination. In the test group, BPRs were not detected until 13 weeks. However, BPRs were detected in the control group by 13 weeks.Conclusion: It was shown that full‐mouth SRP using systemically administered azithromycin was a clinically and bacteriologically useful basic periodontal treatment for severe chronic periodontitis.

1 May 2007 in Journal of Periodontology
Verified
Journal Article
Closed access
Kazuhiro GomiKazuhiro Gomi
Kazuhiro Gomi
AYAkihiro Yashima
Akihiro Yashima
FIFumiaki Iino
Fumiaki Iino
MKMikimoto Kanazashi
Mikimoto Kanazashi
TNTakatoshi Nagano
Takatoshi Nagano
TATakashi Arai
Takashi Arai
Background: Azithromycin is an azalide antibiotic, effective against a wide range of oral bacteria including periodontopathic bacteria. Azithromycin is taken up by phagocytes and is released into inflamed tissue over time. The concentration of azithromycin in inflamed periodontal tissues over time has not been studied. In this study, we determined the azithromycin concentration in the gingiva and inflammatory connective tissue of the periodontal pocket in periodontal patients who had been administered azithromycin systemically. We also evaluated the clinical and microbiologic effects of azithromycin.Methods: Thirty‐four patients with periodontitis were prescribed azithromycin 500 mg once daily for 3 days. During the 14‐day study, clinical parameters (probing depth, gingival index, bleeding on probing, and gingival crevicular fluid level) were recorded, subgingival plaque was collected for bacteriologic examination, and the azithromycin concentration in the tissues lining the periodontal pocket was measured by agar diffusion bioassay.Results: Clinical parameters significantly improved after administration of azithromycin. The total number of cultivated bacteria also significantly decreased by day 4 but slightly increased after day 7. Sustained reduction in levels of six periodontopathic bacteria was not apparent until day 14. On day 7, the azithromycin concentration in the tissues lining the periodontal pockets was 50% of that on day 4, and on day 14 only 20%.Conclusion: Azithromycin is detectable in inflamed periodontal tissues ≥14 days after systemic administration; it is associated with clinical and microbiologic improvement.

19 September 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HIHiroo Itohiya
Hiroo Itohiya
YMYuji Matsushima
Yuji Matsushima
SSSatoshi Shirakawa
Satoshi Shirakawa
SKSohtaro Kajiyama
Sohtaro Kajiyama
AYAkihiro Yashima
Akihiro Yashima
Kazuhiro GomiKazuhiro Gomi
Kazuhiro Gomi
Rapid progress has been made in terms of metal nanoparticles studied in numerous fields. Metal nanoparticles have also been used in medical research, and antibacterial properties and anticancer effects have been reported. However, the underlying mechanism responsible for these effects has not been fully elucidated. Therefore, the present study focused on platinum nanoparticles (PtNPs) and examined their antibacterial properties and functional potential for decomposing organic matter, considering potential applications in the dental field. PtNPs were allowed to react with dental-related bacteria (Streptococcus mutans; Enterococcus faecalis, caries; Porphyromonas gingivalis, and endodontic and periodontal lesions). Antibacterial properties were evaluated by measuring colony formation. In addition, PtNPs were allowed to react with albumin and lipopolysaccharides (LPSs), and the functional potential to decompose organic matter was evaluated. All evaluations were performed in vitro. Colony formation in all bacterial species was completely suppressed by PtNPs at concentrations of >5 ppm. The addition of PtNPs at concentrations of >10 ppm significantly increased fragmentation and decomposition. The addition of PtNPs at concentrations of >125 pico/mL to 1 EU/mL LPS resulted in significant amounts of decomposition and elimination. The results revealed that PtNPs had antibacterial effects against dental-related bacteria and proteolytic potential to decompose proteins and LPS, an inflammatory factor associated with periodontal disease. Therefore, the use and application of PtNPs in periodontal and endodontic treatment is considered promising.

1 June 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IMIchiro Matsuo
Ichiro Matsuo
NKNaoya Kawamura
Naoya Kawamura
YOYoshiki Ohnuki
Yoshiki Ohnuki
KSKenji Suita
Kenji Suita
MIMisao Ishikawa
Misao Ishikawa
SOSatoshi Okumura
Satoshi Okumura
Oral infections, particularly periodontitis, are a well-established risk factor for cardiovascular diseases, although the molecular mechanisms involved remain elusive. The aims of the present study were to investigate the effects of lipopolysaccharide derived from Porphyromonas gingivalis (PG-LPS) on cardiac function in mice, and to elucidate the underlying mechanisms. Mice (C57BL/6) were injected with PG-LPS (0.8 mg/kg/day) with or without an inhibitor of Toll-like receptor 4 (TLR4) signaling (TAK-242, 0.8 mg/kg/day) for 4 weeks. Left ventricular ejection function was significantly decreased at 1 week (from 67 ± 0.5 to 58 ± 1.2%) and remained low at 4 weeks (57 ± 1.0%). The number of apoptotic myocytes was increased (approximately 7.4-fold), the area of fibrosis was increased (approximately 3.3-fold) and the number of 8-hydroxydeoxyguanosine-positive myocytes, a sensitive indicator of oxidative DNA damage, was increased (approximately 7.6-fold) at 4 weeks in the heart of PG-LPS treated mice. However, levels of various serum pro-inflammatory cytokines in PG-LPS-treated mice were similar to those in control mice. The impairment of cardiac function in PG-LPS-treated mice appears to involve activation of TLR4-NADPH oxidase (NOX) 4 signaling, leading to abundant production of reactive oxygen species and Ca2+ leakage from sarcoplastic reticulumn induced by calmodulin kinase II (CaMKII)-mediated phosphorylation of phospholamban (at Thr-17) and ryanodine receptor 2 (at Ser-2448). Pharmacological inhibition of TLR4 with TAK-242 attenuated the changes in cardiac function in PG-LPS-treated mice. Our results indicate that TLR4-NOX4 signaling may be a new therapeutic target for treatment of cardiovascular diseases in patients with periodontitis.

20 November 2015 in Australian Dental Journal
Verified
Journal Article
Closed access
PDF file
Kazuhiro GomiKazuhiro Gomi
Kazuhiro Gomi
YMYuji Matsushima
Yuji Matsushima
YUYuko Ujiie
Yuko Ujiie
SSSatoshi Shirakawa
Satoshi Shirakawa
TNTakatoshi Nagano
Takatoshi Nagano
AYAkihiro Yashima
Akihiro Yashima

3 May 2006 in Journal of Periodontal Research
Verified
Journal Article
Closed access
PDF file
MKM. Kanazashi
M. Kanazashi
Kazuhiro GomiKazuhiro Gomi
Kazuhiro Gomi
TNT. Nagano
T. Nagano
TTT. Tanabe
T. Tanabe
TAT. Arai
T. Arai
MFM. Fukae
M. Fukae